EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Innovative accumulative risk assessment strategy of co-exposure of As and Pb in medical earthworms based on in vivo-in vitro correlation

Tian-Tian Zuo, Jia Zhu, Fei Gao, Ji-Shuang Wang, Qing-Hui Song, Hai-Yan Wang, Lei Sun, Wan-Qiang Zhang, De-Juan Kong, Yuan-Sheng Guo, Jian-Bo Yang, Feng Wei und 3 weitere

Environment International · 2023

DOI: 10.1016/j.envint.2023.107933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environment International, 2023. Verfasst von Tian-Tian Zuo und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes for Food and Drug Control, Beijing 102629, China; WHO Collaborating Center for Herbal Medicine (CHN-139), Beijing, China. Hauptthemen laut MEDLINE: Arsenic, Oligochaeta, Soil Pollutants, Metals, Heavy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes for Food and Drug Control, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies on risks assessment of heavy metal(loid) are usually based on their total concentrations. Nevertheless, such an analysis does not assess their real amounts absorbed by human body. To scientifically assess the health risks, in this study medical earthworms were analyzed for relative bioavailability (RBA) of arsenic (As) and lead (Pb) using a multiple gavage mouse model with liver, kidneys, brain, and leg bones as biomarkers for the first time. Metal(loid) bioaccessibility was determined using in vitro physiologically based extraction (PBET) assay. We are the first to develop a novel accumulative health risk assessment strategy by combinational analyzing bioavailability of heavy metal(loid) levels to calculate target organ toxicity dose (TTD) modification of the HI and total cancer risk (TCR), which has capacity to evaluate the health risks of co-exposure of Pb and As in medical earthworms. As a result, As-RBA ranged from 7.2% to 45.1%, and Pb-RBA ranged from 16.1% to 49.8%. Additionally, As and Pb bioaccessibility varied from 6.7% to 48.3% and 7.8% to 52.5%, respectively. Moreover, strong in vivo-in vitro correlations (IVIVCs) were observed between metal-RBA and bioaccessibility, indicating the robustness of the in vitro PBET assay to predict metal-RBA in medical earthworms. The refined accumulative assessment strategy revealed that when adjusted by heavy metal(loid) bioavailability, the TTD modification of HI method typically exhibited an acceptable health risk caused by the co-exposure of Pb and As for cardiovascular, hematological, neurological, and renal system. The TCR levels associated with exposure to Pb and As due to the ingestion of medical earthworms were also acceptable after adjustment by bioavailability. Collectively, our innovation on accumulative risk assessment based on in vivo-in vitro correlation provides a novel approach engaging in assessing the risks due to co-exposure of As and Pb in medical earthworms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArsenicOligochaetaSoil PollutantsMetals, HeavyAnimalsMiceHumansLeadRisk AssessmentBiological AvailabilityReceptors, Antigen, T-CellSoil

Stichwörter der Autor:innen

Accumulative risk assessmentHeavy metal(loid)sIn vivo-in vitro correlationMedical earthwormsRelative bioavailability

Substanzen

ArsenicLeadSoil PollutantsReceptors, Antigen, T-CellSoilMetals, Heavy

Autor:innen und Institutionen

  • National Institutes for Food and Drug Control, Beijing 102629, China; WHO Collaborating Center for Herbal Medicine (CHN-139), Beijing, China.
  • Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • National Institutes for Food and Drug Control, Beijing 102629, China.
  • Tongliao Market Detection and Testing Center, Tongliao 028000, China.
  • National Institutes for Food and Drug Control, Beijing 102629, China; WHO Collaborating Center for Herbal Medicine (CHN-139), Beijing, China. Electronic address: sansan8251@sina.com.
  • National Institutes for Food and Drug Control, Beijing 102629, China; WHO Collaborating Center for Herbal Medicine (CHN-139), Beijing, China. Electronic address: jhyu@nifdc.org.cn.

Förderung

  • National Institutes for Food and Drug Control
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Zuo, T. T., Zhu, J., Gao, F., Wang, J. S., Song, Q. H., Wang, H. Y., Sun, L., Zhang, W. Q., Kong, D. J., Guo, Y. S., Yang, J. B., Wei, F., Wang, Q., Jin, H. Y., & Ma, S. C. (2023). Innovative accumulative risk assessment strategy of co-exposure of As and Pb in medical earthworms based on in vivo-in vitro correlation. Environment International. https://doi.org/10.1016/j.envint.2023.107933

Vancouver

Zuo TT, Zhu J, Gao F, Wang JS, Song QH, Wang HY, et al. Innovative accumulative risk assessment strategy of co-exposure of As and Pb in medical earthworms based on in vivo-in vitro correlation. Environment International. 2023. doi:10.1016/j.envint.2023.107933

BibTeX
@article{Zuo2023,
  author = {Zuo, Tian-Tian and Zhu, Jia and Gao, Fei and Wang, Ji-Shuang and Song, Qing-Hui and Wang, Hai-Yan and Sun, Lei and Zhang, Wan-Qiang and Kong, De-Juan and Guo, Yuan-Sheng and Yang, Jian-Bo and Wei, Feng and Wang, Qi and Jin, Hong-Yu and Ma, Shuang-Cheng},
  title = {Innovative accumulative risk assessment strategy of co-exposure of As and Pb in medical earthworms based on in vivo-in vitro correlation},
  journal = {Environment International},
  year = {2023},
  doi = {10.1016/j.envint.2023.107933}
}
Kostenlos starten →